Advanced search
Start date
Betweenand


Cellular immune responses to Bacillus Calmette-Guerin vaccine from health and human immunodeficiency virus-exposed.

Full text
Author(s):
Taís Nitsch Mazzola
Total Authors: 1
Document type: Master's Dissertation
Press: Campinas, SP.
Institution: Universidade Estadual de Campinas (UNICAMP). Faculdade de Ciências Médicas
Defense date:
Examining board members:
Maria Marluce dos Santos Vilela; Maria Heloisa de Souza Lima Blotta; Luciana Cezar de Cerqueira Leite
Advisor: Marcos Tadeu Nolasco da Silva; Maria Marluce dos Santos Vilela
Abstract

The objectives of this study were to evaluate cell-mediated immune response to Bacillus Calmette-Guérin (BCG) vaccination in infants vaccinated with combined or separated BCG and Hepatitis B and to compare with BCG-specific response from uninfected infants with vertical exposure to Human Immunodeficiency Virus-1 (HIV-1). BCG-specific proliferation by flow cytometry and IL-10, IL-12, IFN-? and TNF-a concentrations by ELISA were similar in PBMC from infants vaccinated with combined or separated BCG and Hepatitis B. There was CD4+, CD8+ and remarkable ?d+ T cell proliferation in BCG-stimulated cultures. The results suggested that the combined BCG and Hepatitis B vaccine was as immunogenic as BCG vaccine inoculated alone. Exposed HIV-uninfected infants were recruited at Pediatrics Out-Patients Unit of Hospital das Clínicas in UNICAMP and separated into three groups: E1 (aged 6.7-8.8 months), E2 (aged 9.1-17.1) and E3 (aged 18.1-23.4). Unexposed infants (UE, aged 7.0-8.7 months) and E1 matched for age. Proliferation in cell cultures with BCG was significantly reduced in all exposed groups in comparison to UE. Only BCG-stimulated cultures from E3 were similar to UE in relation to CD4+, CD8+ and ?d+ T cell subsets. TNF-a and IL-10 production was not different in BCG-stimulated cultures of unexposed and exposed infants from all groups and there were lower IFN-? concentration in the samples from E1 in comparison to all of the other groups. The results demonstrated a delay in immune system development of HIV-exposed infants (AU)